Farfel Gail M
Insider CIK 1614780 · DRRX Director · MRNS Chief Clinical Dev & Reg Offic · PMN Chief Executive Officer, Director · ZGNX See Remarks · AVRO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DRRX DURECT CORP | D To issuer deriv | 2025-09-11 | 2025-09-12 | 5,500 | — | $0 | 0 | SEC↗ |
| DRRX DURECT CORP | D To issuer deriv | 2025-09-11 | 2025-09-12 | 7,000 | — | $0 | 0 | SEC↗ |
| DRRX DURECT CORP | D To issuer deriv | 2025-09-11 | 2025-09-12 | 5,500 | — | $0 | 0 | SEC↗ |
| DRRX DURECT CORP | D To issuer deriv | 2025-09-11 | 2025-09-12 | 5,500 | — | $0 | 0 | SEC↗ |
| DRRX DURECT CORP | D To issuer deriv | 2025-09-11 | 2025-09-12 | 5,500 | — | $0 | 0 | SEC↗ |
| DRRX DURECT CORP | U Tender | 2025-09-11 | 2025-09-12 | 15,500 | — | $0 | 0 | SEC↗ |
| DRRX DURECT CORP | M Exercise deriv | 2025-09-10 | 2025-09-11 | 5,500 | — | $0 | 0 | SEC↗ |
| DRRX DURECT CORP | M Exercise | 2025-09-10 | 2025-09-11 | 5,500 | $1.22 | $6.7K | 15,500 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2024-09-25 | 2024-09-27 | 5,500 | — | $0 | 5,500 | SEC↗ |
| PMN ProMIS Neurosciences Inc. | A Award deriv | 2023-08-23 | 2023-08-25 | 53,192 | — | $0 | 53,192 | SEC↗ |
| PMN ProMIS Neurosciences Inc. | A Award | 2023-08-23 | 2023-08-25 | 53,192 | — | $0 | 55,192 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2023-06-21 | 2023-06-23 | 5,500 | — | $0 | 5,500 | SEC↗ |
| AVRO AVROBIO, Inc. | A Award deriv | 2023-06-06 | 2023-06-08 | 17,643 | — | $0 | 17,643 | SEC↗ |
| PMN ProMIS Neurosciences Inc. | P Buy | 2022-12-14 | 2022-12-16 | 1,000 | $4.94 | $4.9K | 2,000 | SEC↗ |
| PMN ProMIS Neurosciences Inc. | P Buy | 2022-12-06 | 2022-12-08 | 1,000 | $5.70 | $5.7K | 1,000 | SEC↗ |
| PMN ProMIS Neurosciences Inc. | A Award deriv | 2022-09-19 | 2022-09-20 | 208,334 | — | $0 | 208,334 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2022-06-15 | 2022-06-17 | 55,000 | — | $0 | 55,000 | SEC↗ |
| AVRO AVROBIO, Inc. | A Award deriv | 2022-06-08 | 2022-06-10 | 17,478 | — | $0 | 17,478 | SEC↗ |
| AVRO AVROBIO, Inc. | A Award deriv | 2022-06-08 | 2022-06-10 | 17,478 | — | $0 | 17,478 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2022-05-18 | 2022-05-18 | 29,911 | $0.41 | $12.3K | 100,000 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2022-05-16 | 2022-05-18 | 25,300 | $0.39 | $9.9K | 70,089 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2022-05-13 | 2022-05-13 | 9,250 | $0.40 | $3.7K | 44,789 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2022-05-12 | 2022-05-13 | 1,500 | $0.39 | $585 | 35,539 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2022-05-11 | 2022-05-13 | 9,950 | $0.40 | $4.0K | 34,039 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2022-05-10 | 2022-05-10 | 4,250 | $0.40 | $1.7K | 21,750 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2022-05-10 | 2022-05-12 | 2,339 | $0.41 | $959 | 24,089 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2022-05-09 | 2022-05-10 | 17,500 | $0.39 | $6.8K | 17,500 | SEC↗ |
| ZGNX ZOGENIX, INC. | D To issuer deriv | 2022-03-07 | 2022-03-09 | 52,500 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | D To issuer deriv | 2022-03-07 | 2022-03-09 | 30,000 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | D To issuer deriv | 2022-03-07 | 2022-03-09 | 35,000 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | D To issuer deriv | 2022-03-07 | 2022-03-09 | 40,187 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | D To issuer deriv | 2022-03-07 | 2022-03-09 | 45,000 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | D To issuer deriv | 2022-03-07 | 2022-03-09 | 14,250 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | D To issuer deriv | 2022-03-07 | 2022-03-09 | 30,289 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | U Tender | 2022-03-07 | 2022-03-09 | 16,606 | — | $0 | 0 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2021-06-15 | 2021-06-16 | 55,000 | — | $0 | 55,000 | SEC↗ |
| AVRO AVROBIO, Inc. | A Award deriv | 2021-06-10 | 2021-06-14 | 17,438 | — | $0 | 17,438 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2021-03-26 | 2021-03-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2021-03-26 | 2021-03-30 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise deriv | 2021-03-15 | 2021-03-17 | 1,500 | — | $0 | 4,500 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise deriv | 2021-03-15 | 2021-03-17 | 2,031 | — | $0 | 4,062 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise deriv | 2021-03-15 | 2021-03-17 | 1,625 | — | $0 | 1,625 | SEC↗ |
| ZGNX ZOGENIX, INC. | F Tax w/h | 2021-03-15 | 2021-03-17 | 542 | $20.70 | $11.2K | 14,776 | SEC↗ |
| ZGNX ZOGENIX, INC. | F Tax w/h | 2021-03-15 | 2021-03-17 | 735 | $20.70 | $15.2K | 13,818 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise | 2021-03-15 | 2021-03-17 | 1,500 | — | $0 | 15,318 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise | 2021-03-15 | 2021-03-17 | 2,031 | — | $0 | 14,553 | SEC↗ |
| ZGNX ZOGENIX, INC. | F Tax w/h | 2021-03-15 | 2021-03-17 | 587 | $20.70 | $12.2K | 12,522 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise | 2021-03-15 | 2021-03-17 | 1,625 | — | $0 | 13,109 | SEC↗ |
| AVRO AVROBIO, Inc. | A Award deriv | 2020-10-19 | 2020-10-21 | 28,000 | — | $0 | 28,000 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise deriv | 2020-06-25 | 2020-06-29 | 8,750 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | F Tax w/h | 2020-06-25 | 2020-06-29 | 3,044 | — | $0 | 11,179 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise | 2020-06-25 | 2020-06-29 | 8,750 | — | $0 | 14,223 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2020-06-17 | 2020-06-18 | 55,000 | — | $0 | 55,000 | SEC↗ |
| ZGNX ZOGENIX, INC. | S Sale | 2020-05-12 | 2020-05-13 | 2,573 | $28.21 | $72.6K | 5,048 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise deriv | 2020-03-15 | 2020-03-17 | 2,032 | — | $0 | 6,093 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise deriv | 2020-03-15 | 2020-03-17 | 1,625 | — | $0 | 3,250 | SEC↗ |
| ZGNX ZOGENIX, INC. | F Tax w/h | 2020-03-15 | 2020-03-17 | 525 | $22.01 | $11.6K | 6,285 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise | 2020-03-15 | 2020-03-17 | 1,625 | — | $0 | 6,810 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise | 2020-03-15 | 2020-03-17 | 2,032 | — | $0 | 8,317 | SEC↗ |
| ZGNX ZOGENIX, INC. | F Tax w/h | 2020-03-15 | 2020-03-17 | 696 | $22.01 | $15.3K | 7,621 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2020-03-04 | 2020-03-06 | 35,000 | — | $0 | 35,000 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2020-03-04 | 2020-03-06 | 6,000 | — | $0 | 6,000 | SEC↗ |
| ZGNX ZOGENIX, INC. | S Sale | 2019-08-22 | 2019-08-23 | 3,446 | $52.00 | $179.2K | 4,891 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2019-04-23 | 2019-04-25 | 70,000 | — | $0 | 70,000 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2019-03-22 | 2019-03-26 | 8,125 | — | $0 | 8,125 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2019-03-22 | 2019-03-26 | 63,750 | — | $0 | 63,750 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise deriv | 2019-03-15 | 2019-03-19 | 1,625 | — | $0 | 4,875 | SEC↗ |
| ZGNX ZOGENIX, INC. | F Tax w/h | 2019-03-15 | 2019-03-19 | 488 | $51.88 | $25.3K | 8,337 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise | 2019-03-15 | 2019-03-19 | 1,625 | — | $0 | 8,825 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise deriv | 2018-10-04 | 2018-10-09 | 6,961 | $13.96 | $97.2K | 30,289 | SEC↗ |
| ZGNX ZOGENIX, INC. | S Sale | 2018-10-04 | 2018-10-09 | 1,961 | $43.74 | $85.8K | 7,143 | SEC↗ |
| ZGNX ZOGENIX, INC. | S Sale | 2018-10-04 | 2018-10-09 | 2,900 | $43.11 | $125.0K | 9,104 | SEC↗ |
| ZGNX ZOGENIX, INC. | S Sale | 2018-10-04 | 2018-10-09 | 2,100 | $42.92 | $90.1K | 12,004 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise | 2018-10-04 | 2018-10-09 | 6,961 | $13.96 | $97.2K | 14,104 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise deriv | 2018-09-04 | 2018-09-05 | 7,000 | $13.96 | $97.7K | 37,250 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise | 2018-09-04 | 2018-09-05 | 7,000 | $13.96 | $97.7K | 14,143 | SEC↗ |
| ZGNX ZOGENIX, INC. | S Sale | 2018-09-04 | 2018-09-05 | 4,700 | $47.27 | $222.2K | 9,443 | SEC↗ |
| ZGNX ZOGENIX, INC. | S Sale | 2018-09-04 | 2018-09-05 | 2,300 | $48.21 | $110.9K | 7,143 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise deriv | 2018-08-08 | 2018-08-10 | 7,000 | — | $0 | 44,250 | SEC↗ |
| ZGNX ZOGENIX, INC. | S Sale | 2018-08-08 | 2018-08-10 | 5,100 | $52.42 | $267.3K | 9,043 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise | 2018-08-08 | 2018-08-10 | 7,000 | $13.96 | $97.7K | 14,143 | SEC↗ |
| ZGNX ZOGENIX, INC. | S Sale | 2018-08-08 | 2018-08-10 | 1,900 | $53.16 | $101.0K | 7,143 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise deriv | 2018-06-12 | 2018-06-13 | 5,000 | — | $0 | 51,250 | SEC↗ |
| ZGNX ZOGENIX, INC. | S Sale | 2018-06-12 | 2018-06-13 | 5,118 | $45.00 | $230.3K | 7,143 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise | 2018-06-12 | 2018-06-13 | 5,000 | $13.96 | $69.8K | 12,261 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2018-03-15 | 2018-03-16 | 6,500 | — | $0 | 6,500 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2018-03-15 | 2018-03-16 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2017-03-14 | 2017-03-16 | 52,500 | — | $0 | 52,500 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2017-03-14 | 2017-03-16 | 8,750 | — | $0 | 8,750 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2016-03-14 | 2016-03-16 | 45,000 | — | $0 | 45,000 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2015-10-05 | 2015-10-07 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2015-07-01 | 2015-07-06 | 56,250 | — | $0 | 56,250 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | M Exercise deriv | 2015-04-21 | 2015-04-23 | 30,000 | — | $0 | 8,462 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | M Exercise | 2015-04-21 | 2015-04-23 | 30,000 | $1.04 | $31.2K | 30,000 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | S Sale | 2015-04-21 | 2015-04-23 | 30,000 | $9.48 | $284.4K | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award deriv | 2014-12-22 | 2014-12-23 | 43,000 | — | $0 | 43,000 | SEC↗ |